BridgeBio Pharma, Inc. · NASDAQ:BBIO
Apuli Maricel sold 2,000 BridgeBio Pharma, Inc. shares (Form 4)
Traded Oct 30, 2026 · Filed Nov 3, 2026
On Oct 30, 2026, Apuli Maricel (Chief Accounting Officer) sold 2,000 BridgeBio Pharma, Inc. shares at US$72.85 for US$146K under a trading plan, leaving 120,687 shares. Filed Nov 3, 2026 (Form 4).
- Sold
- 2,000 shares
- Price
- US$72.85
- Value
- US$146K
- Holding after
- 120,687 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Common Stock | Sale | 2,000 | US$72.85 | 120,687 | Direct |
Source
Download original · View original at SEC
Related
- BridgeBio Pharma, Inc.
- Apuli Maricel
- BridgeBio Pharma, Inc. shareholders
- Form 4 · Apuli Maricel · Nov 18, 2026
- Form 4 · Apuli Maricel · Aug 18, 2026
- Form 4 · Apuli Maricel · Aug 3, 2026
- Form 4 · Apuli Maricel · May 19, 2026
- Form 4 · Apuli Maricel · May 4, 2026
- Form 4 · Kumar Neil · Nov 20, 2026
- Form 4 · Kumar Neil · Nov 18, 2026
- Form 4 · Trimarchi Thomas · Nov 18, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 12, 2026
- Schedule 13G · BlackRock, Inc. · Oct 27, 2026